The angle between your iris and cornea is vital in maintaining eye health. A wide angle typically allows for proper fluid drainage, while a narrow angle can affect eye function. But there’s no ...
BEDFORD, Mass.--(BUSINESS WIRE)--Ocular Therapeutix™, Inc. (NASDAQ: OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for ...
BEDFORD, Mass.--(BUSINESS WIRE)--Ocular Therapeutix™, Inc. (NASDAQ: OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for ...
The Food and Drug Administration (FDA) has approved Durysta (bimatoprost implant; Allergan) for the reduction of intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension.
Glaucoma is the most common cause of blindness in older adults. The condition involves damage to the eye’s optic nerve, and without treatment, it can lead to vision loss or blindness. Glaucoma is a ...
The front area of our eyes contains fluid. When these fluids don’t drain properly from your eyes, pressure can build up inside them. Having a higher-than-normal pressure in your eyes is called ocular ...
Without treatment, glaucoma can cause irreversible, progressive vision loss and blindness. The progression rate may depend on the type of glaucoma someone has. Glaucoma is a progressive condition that ...
Omlonti is a relatively selective EP2 receptor agonist designed to increase aqueous humor drainage through the conventional (or trabecular) and uveoscleral outflow pathways. The Food and Drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results